Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Colorectal Neoplasms

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 83 articles:
HTML format
Text format



Single Articles


    February 2012
  1. SLATTERY ML , Lundgreen A, Herrick JS, Kadlubar S, et al
    Genetic variation in bone morphogenetic protein and colon and rectal cancer.
    Int J Cancer. 2012;130:653-64.
    PubMed     Text format     Related articles    Abstract available



  2. TIERLING S , Sers C, Lehmann A, Walter J, et al
    A fast, cost-efficient and sensitive approach for KRAS mutation detection using multiplexed primer extension with IP/RP-HPLC separation.
    Int J Cancer. 2012;130:567-74.
    PubMed     Text format     Related articles    Abstract available



    January 2012
  3. LEE CM , Jang D, Cheong SJ, Jeong MH, et al
    Optical imaging of MMP expression and cancer progression in an inflammation-induced colon cancer model.
    Int J Cancer. 2012 Jan 27. doi: 10.1002/ijc.27451.
    PubMed     Text format     Related articles    Abstract available



  4. RUDOLPH A , Hein R, Hoffmeister M, Forsti A, et al
    Copy number variations of GSTT1 and GSTM1, colorectal cancer risk and possible effect modification of cigarette smoking and menopausal hormone therapy.
    Int J Cancer. 2012 Jan 10. doi: 10.1002/ijc.27428.
    PubMed     Text format     Related articles    Abstract available



  5. PANDEY MK , Liu G, Cooper TK, Mulder KM, et al
    Knockdown of c-Fos suppresses the growth of human colon carcinoma cells in athymic mice.
    Int J Cancer. 2012;130:213-22.
    PubMed     Text format     Related articles    Abstract available



    December 2011
  6. ZUR HAUSEN H
    Red meat consumption and cancer: Reasons to suspect involvement of bovine infectious factors in colorectal cancer.
    Int J Cancer. 2011 Dec 31. doi: 10.1002/ijc.27413.
    PubMed     Text format     Related articles    Abstract available



  7. JIRASKOVA A , Novotny J, Novotny L, Vodicka P, et al
    Association of serum bilirubin and promoter variations in HMOX1 and UGT1A1 genes with sporadic colorectal cancer.
    Int J Cancer. 2011 Dec 31. doi: 10.1002/ijc.27412.
    PubMed     Text format     Related articles    Abstract available



  8. SVEEN A , Bakken AC, Agesen TH, Lind GE, et al
    The exon-level biomarker SLC39A14 has organ-confined cancer-specificity in colorectal cancer.
    Int J Cancer. 2011 Dec 15. doi: 10.1002/ijc.27399.
    PubMed     Text format     Related articles    Abstract available



  9. OSTER B , Thorsen K, Lamy P, Wojdacz TK, et al
    Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas.
    Int J Cancer. 2011;129:2855-66.
    PubMed     Text format     Related articles    Abstract available



  10. KEY TJ , Appleby PN, Masset G, Brunner EJ, et al
    Vitamins, minerals, essential fatty acids and colorectal cancer risk in the United Kingdom dietary cohort consortium.
    Int J Cancer. 2011 Dec 3. doi: 10.1002/ijc.27386.
    PubMed     Text format     Related articles    Abstract available



  11. INOUE I , Mukoubayashi C, Yoshimura N, Niwa T, et al
    Elevated risk of colorectal adenoma with Helicobacter pylori-related chronic gastritis: a population-based case-control study.
    Int J Cancer. 2011;129:2704-11.
    PubMed     Text format     Related articles    Abstract available



    November 2011
  12. LEE SK , Han YM, Yun J, Lee CW, et al
    PRL-3 promotes migration and invasion by up-regulating MMP-7 in human colorectal cancer cells.
    Int J Cancer. 2011 Nov 30. doi: 10.1002/ijc.27381.
    PubMed     Text format     Related articles    Abstract available



  13. LIM SW , Kim HR, Kim HY, Huh JW, et al
    High-frequency minisatellite instability of the mitochondrial genome in colorectal cancer tissue associated with clinicopathological values.
    Int J Cancer. 2011 Nov 28. doi: 10.1002/ijc.27375.
    PubMed     Text format     Related articles    Abstract available



  14. AKAGI T , Hijiya N, Inomata M, Shiraishi N, et al
    Visinin-like protein-1 (VSNL-1) overexpression is an indicator of lymph node metastasis and poor prognosis in colorectal cancer patients.
    Int J Cancer. 2011 Nov 2. doi: 10.1002/ijc.27341.
    PubMed     Text format     Related articles    Abstract available



    October 2011
  15. MORIKAWA T , Kuchiba A, Liao X, Imamura Y, et al
    Tumor TP53 expression status, body mass index, and prognosis in colorectal cancer.
    Int J Cancer. 2011 Oct 31. doi: 10.1002/ijc.26495.
    PubMed     Text format     Related articles    Abstract available



  16. SONG Y , Xu Y, Wang Z, Chen Y, et al
    MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer.
    Int J Cancer. 2011 Oct 23. doi: 10.1002/ijc.26485.
    PubMed     Text format     Related articles    Abstract available



  17. CASSINOTTI E , Melson J, Liggett T, Melnikov A, et al
    DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polyps.
    Int J Cancer. 2011 Oct 23. doi: 10.1002/ijc.26484.
    PubMed     Text format     Related articles    Abstract available



  18. YHIM HY , Lee NR, Song EK, Kwak JY, et al
    The prognostic significance of tumor human papillomavirus status for patients with anal squamous cell carcinoma treated with combined chemoradiotherapy.
    Int J Cancer. 2011;129:1752-60.
    PubMed     Text format     Related articles    Abstract available



  19. DURATURO F , Liccardo R, Cavallo A, De Rosa M, et al
    Association of low-risk MSH3 and MSH2 variant alleles with Lynch syndrome: probability of synergistic effects.
    Int J Cancer. 2011;129:1643-50.
    PubMed     Text format     Related articles    Abstract available



    September 2011
  20. MCCAWLEY N , Conlon S, Hector S, Cummins RJ, et al
    Analysis of proteasomal subunit expression reveals Rpt4 as a prognostic marker in stage II colorectal cancer.
    Int J Cancer. 2011 Sep 29. doi: 10.1002/ijc.26468.
    PubMed     Text format     Related articles    Abstract available



  21. MODEST DP , Jung A, Moosmann N, Laubender RP, et al
    The influence of KRAS- and BRAF-mutations on the efficacy of cetuximab-based 1st-line therapy of metastatic colorectal cancer: An analysis of the AIO KRK-0104 -trial.
    Int J Cancer. 2011 Sep 29. doi: 10.1002/ijc.26467.
    PubMed     Text format     Related articles    Abstract available



  22. BOSSARD C , Bezieau S, Matysiak-Budnik T, Volteau C, et al
    HLA-E/beta2 microglobulin over-expression in colorectal cancer is associated with recruitment of inhibitory immune cells and tumor progression.
    Int J Cancer. 2011 Sep 22. doi: 10.1002/ijc.26453.
    PubMed     Text format     Related articles    Abstract available



  23. ALGARS A , Irjala H, Vaittinen S, Huhtinen H, et al
    Type and location of tumor-infiltrating macrophages and lymphatic vessels predict survival of colorectal cancer patients.
    Int J Cancer. 2011 Sep 22. doi: 10.1002/ijc.26457.
    PubMed     Text format     Related articles    Abstract available



  24. VAYRYNEN JP , Vornanen J, Tervahartiala T, Sorsa T, et al
    Serum MMP-8 levels increase in colorectal cancer and correlate with disease course and inflammatory properties of primary tumors.
    Int J Cancer. 2011 Sep 14. doi: 10.1002/ijc.26435.
    PubMed     Text format     Related articles    Abstract available



  25. LEE JH , Kim TI, Jeon SM, Hong SP, et al
    The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus.
    Int J Cancer. 2011 Sep 12. doi: 10.1002/ijc.26421.
    PubMed     Text format     Related articles    Abstract available



    August 2011
  26. VIJAYARAGHAVAN A , Efrusy MB, Goke B, Kirchner T, et al
    Cost-effectiveness of KRAS testing in metastatic colorectal cancer patients in the United States and Germany.
    Int J Cancer. 2011 Aug 26. doi: 10.1002/ijc.26400.
    PubMed     Text format     Related articles    Abstract available



  27. SIRNES S , Bruun J, Kolberg M, Kjenseth A, et al
    Connexin43 acts as a colorectal cancer tumor suppressor and predicts disease outcome.
    Int J Cancer. 2011 Aug 22. doi: 10.1002/ijc.26392.
    PubMed     Text format     Related articles    Abstract available



  28. HANSEN L , Skeie G, Landberg R, Lund E, et al
    Intake of dietary fiber, especially from cereal foods, is associated with lower incidence of colon cancer in the HELGA cohort.
    Int J Cancer. 2011 Aug 22. doi: 10.1002/ijc.26381.
    PubMed     Text format     Related articles    Abstract available



  29. NOCK NL , Patrick-Melin A, Cook M, Thompson C, et al
    Higher bone mineral density is associated with a decreased risk of colorectal adenomas.
    Int J Cancer. 2011;129:956-64.
    PubMed     Text format     Related articles    Abstract available



  30. SAELAND E , Belo AI, Mongera S, van Die I, et al
    Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients.
    Int J Cancer. 2011 Aug 5. doi: 10.1002/ijc.26354.
    PubMed     Text format     Related articles    Abstract available



  31. TERAOKA N , Mutoh M, Takasu S, Ueno T, et al
    High susceptibility to azoxymethane-induced colorectal carcinogenesis in obese KK-Ay mice.
    Int J Cancer. 2011;129:528-35.
    PubMed     Text format     Related articles    Abstract available



    July 2011
  32. BENSON VS , Atkin WS, Green J, Nadel MR, et al
    Towards standardizing and reporting colorectal cancer screening indicators on an international level: The international colorectal cancer screening network (ICRCSN).
    Int J Cancer. 2011 Jul 25. doi: 10.1002/ijc.26310.
    PubMed     Text format     Related articles    Abstract available



  33. PARK SY , Lee SH, Kawasaki N, Itoh S, et al
    alpha1-3/4 fucosylation at Asn 241 of beta-haptoglobin is a novel marker for colon cancer: a combinatorial approach for development of glycan biomarkers.
    Int J Cancer. 2011 Jul 21. doi: 10.1002/ijc.26288.
    PubMed     Text format     Related articles    Abstract available



  34. HIRASHIMA Y , Yamada Y, Tateishi U, Kato K, et al
    Pharmacokinetic parameters from 3-Tesla DCE-MRI as surrogate biomarkers of antitumor effects of bevacizumab plus FOLFIRI in colorectal cancer with liver metastasis.
    Int J Cancer. 2011 Jul 21. doi: 10.1002/ijc.26282.
    PubMed     Text format     Related articles    Abstract available



  35. FIGUEIREDO JC , Mott LA, Giovannucci E, Wu K, et al
    Folic acid and prevention of colorectal adenomas: a combined analysis of randomized clinical trials.
    Int J Cancer. 2011;129:192-203.
    PubMed     Text format     Related articles    Abstract available



  36. NIEUWENHUIS MH , Casparie M, Mathus-Vliegen LM, Dekkers OM, et al
    A nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses.
    Int J Cancer. 2011;129:256-61.
    PubMed     Text format     Related articles    Abstract available



    June 2011
  37. ZUZGA DS , Pelta-Heller J, Li P, Bombonati A, et al
    Phosphorylation of vasodilator-stimulated phosphoprotein ser239 suppresses filopodia and invadopodia in colon cancer.
    Int J Cancer. 2011 Jun 23. doi: 10.1002/ijc.26257.
    PubMed     Text format     Related articles    Abstract available



  38. YADAV VR , Prasad S, Sung B, Gelovani JG, et al
    Boswellic acid inhibits growth and metastasis of human colorectal cancer in orthotopic mouse model by downregulating inflammatory, proliferative, invasive, and angiogenic biomarkers.
    Int J Cancer. 2011 Jun 23. doi: 10.1002/ijc.26251.
    PubMed     Text format     Related articles    Abstract available



  39. HO-PUN-CHEUNG A , Assenat E, Bascoul-Mollevi C, Bibeau F, et al
    EGFR and HER3 mRNA expression levels predict distant metastases in locally advanced rectal cancer.
    Int J Cancer. 2011;128:2938-46.
    PubMed     Text format     Related articles    Abstract available



  40. SARRABAYROUSE G , Corvaisier M, Ouisse LH, Bossard C, et al
    Tumor-reactive CD4+ CD8alphabeta+ CD103+ alphabetaT cells: a prevalent tumor-reactive T-cell subset in metastatic colorectal cancers.
    Int J Cancer. 2011;128:2923-32.
    PubMed     Text format     Related articles    Abstract available



  41. MA Y , Zhang P, Yang J, Liu Z, et al
    Candidate MicroRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation.
    Int J Cancer. 2011 Jun 13. doi: 10.1002/ijc.26232.
    PubMed     Text format     Related articles    Abstract available



  42. SLATTERY ML , Curtin K, Poole EM, Duggan DJ, et al
    Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival.
    Int J Cancer. 2011;128:2726-34.
    PubMed     Text format     Related articles    Abstract available



  43. LEMMENS VE , Klaver YL, Verwaal VJ, Rutten HJ, et al
    Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study.
    Int J Cancer. 2011;128:2717-25.
    PubMed     Text format     Related articles    Abstract available



  44. SCONOCCHIA G , Zlobec I, Lugli A, Calabrese D, et al
    Tumor infiltration by FcgammaRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma.
    Int J Cancer. 2011;128:2663-72.
    PubMed     Text format     Related articles    Abstract available



  45. WANG R , Dashwood WM, Nian H, Lohr CV, et al
    NADPH oxidase overexpression in human colon cancers and rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
    Int J Cancer. 2011;128:2581-90.
    PubMed     Text format     Related articles    Abstract available



    May 2011
  46. BUGNI JM , Al-Rabadi L, Jubbal K, Karagiannides I, et al
    The neurotensin receptor-1 promotes tumor development in a sporadic but not an inflammation-associated mouse model of colon cancer.
    Int J Cancer. 2011 May 31. doi: 10.1002/ijc.26208.
    PubMed     Text format     Related articles    Abstract available



  47. WANG J , Joshi AD, Corral R, Siegmund KD, et al
    Carcinogen metabolism genes, red meat and poultry intake, and colorectal cancer risk.
    Int J Cancer. 2011 May 26. doi: 10.1002/ijc.26199.
    PubMed     Text format     Related articles    Abstract available



  48. OHLSSON L , Israelsson A, Oberg A, Palmqvist R, et al
    Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer.
    Int J Cancer. 2011 May 26. doi: 10.1002/ijc.26182.
    PubMed     Text format     Related articles    Abstract available



  49. CORREALE P , Botta C, Cusi M, Del Vecchio M, et al
    Cetuximab +/- chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro.
    Int J Cancer. 2011 May 26. doi: 10.1002/ijc.26181.
    PubMed     Text format     Related articles    Abstract available



  50. HASAN MR , Ho SH, Owen D, Tai IT, et al
    VEGF inhibitors induce cellular senescence in colorectal cancer cells.
    Int J Cancer. 2011 May 26. doi: 10.1002/ijc.26179.
    PubMed     Text format     Related articles    Abstract available



  51. PALA V , Sieri S, Berrino F, Vineis P, et al
    Yogurt consumption and risk of colorectal cancer in the italian EPIC cohort.
    Int J Cancer. 2011 May 23. doi: 10.1002/ijc.26193.
    PubMed     Text format     Related articles    Abstract available



  52. BRENNER H , Bouvier AM, Foschi R, Hackl M, et al
    Progress in colorectal cancer survival in Europe, from the late 1980s to the early 21st century: The EUROCARE study.
    Int J Cancer. 2011 May 23. doi: 10.1002/ijc.26192.
    PubMed     Text format     Related articles    Abstract available



  53. NISSAN A , Stojadinovic A, Mitrani-Rosenbaum S, Halle D, et al
    Colon cancer associated transcript-1 (CCAT1): A novel RNA expressed in malignant and pre-malignant human tissues.
    Int J Cancer. 2011 May 5. doi: 10.1002/ijc.26170.
    PubMed     Text format     Related articles    Abstract available



  54. ALHOPURO P , Sammalkorpi H, Niittymaki I, Bistrom M, et al
    Candidate driver genes in microsatellite-unstable colorectal cancer.
    Int J Cancer. 2011 May 4. doi: 10.1002/ijc.26167.
    PubMed     Text format     Related articles   



    April 2011
  55. BAO Y , Nimptsch K, Chan AT, Ng K, et al
    Reported behavior of eating anything at anytime and risk of colorectal cancer in women.
    Int J Cancer. 2011 Apr 25. doi: 10.1002/ijc.26150.
    PubMed     Text format     Related articles   



  56. PEDERSEN JW , Blixt O, Bennett EP, Tarp MA, et al
    Seromic profiling of colorectal cancer patients with novel glycopeptide microarray.
    Int J Cancer. 2011;128:1860-71.
    PubMed     Text format     Related articles    Abstract available



  57. LANCASHIRE LJ , Roberts DL, Dive C, Renehan AG, et al
    The development of composite circulating biomarker models for use in anticancer drug clinical development.
    Int J Cancer. 2011;128:1843-51.
    PubMed     Text format     Related articles    Abstract available



  58. YAO Q , Cao S, Li C, Mengesha A, et al
    Micro-RNA-21 regulates TGF-beta-induced myofibroblast differentiation by targeting PDCD4 in tumor-stroma interaction.
    Int J Cancer. 2011;128:1783-92.
    PubMed     Text format     Related articles    Abstract available



    March 2011
  59. KNOWLES JP , Shiwen X, Haque SU, Bhalla A, et al
    Endothelin-1 stimulates colon cancer adjacent fibroblasts.
    Int J Cancer. 2011 Mar 28. doi: 10.1002/ijc.26090.
    PubMed     Text format     Related articles    Abstract available



  60. IEDA J , Yokoyama S, Tamura K, Takifuji K, et al
    Re-expression of CEACAM1 long cytoplasmic domain isoform is associated with invasion and migration of colorectal cancer.
    Int J Cancer. 2011 Mar 16. doi: 10.1002/ijc.26072.
    PubMed     Text format     Related articles    Abstract available



  61. LEUFKENS AM , van Duijnhoven FJ, Boshuizen HC, Siersema PD, et al
    Educational level and risk of colorectal cancer in EPIC with specific reference to tumor location.
    Int J Cancer. 2011 Mar 15. doi: 10.1002/ijc.26030.
    PubMed     Text format     Related articles   



  62. LIU WM , Gravett AM, Dalgleish AG
    The antimalarial agent artesunate possesses anticancer properties that can be enhanced by combination strategies.
    Int J Cancer. 2011;128:1471-80.
    PubMed     Text format     Related articles    Abstract available



  63. MOREAU M , Mourah S, Dosquet C
    beta-Catenin and NF-kappaB cooperate to regulate the uPA/uPAR system in cancer cells.
    Int J Cancer. 2011;128:1280-92.
    PubMed     Text format     Related articles    Abstract available



  64. WEISS JV , Klein-Scory S, Kubler S, Reinacher-Schick A, et al
    Soluble E-cadherin as a serum biomarker candidate: elevated levels in patients with late-stage colorectal carcinoma and FAP.
    Int J Cancer. 2011;128:1384-92.
    PubMed     Text format     Related articles    Abstract available



  65. SHIMA K , Nosho K, Baba Y, Cantor M, et al
    Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review.
    Int J Cancer. 2011;128:1080-94.
    PubMed     Text format     Related articles    Abstract available



  66. VAN MARCK V , Stove C, Jacobs K, Van den Eynden G, et al
    P-cadherin in adhesion and invasion: opposite roles in colon and bladder carcinoma.
    Int J Cancer. 2011;128:1031-44.
    PubMed     Text format     Related articles    Abstract available



  67. WU D , Matsushita K, Matsubara H, Nomura F, et al
    An alternative splicing isoform of eukaryotic initiation factor 4H promotes tumorigenesis in vivo and is a potential therapeutic target for human cancer.
    Int J Cancer. 2011;128:1018-30.
    PubMed     Text format     Related articles    Abstract available



  68. SARKAR D , Shields B, Davies ML, Muller J, et al
    Brachyury confers cancer stem cell characteristics on colorectal cancer cells.
    Int J Cancer. 2011 Mar 1. doi: 10.1002/ijc.26029.
    PubMed     Text format     Related articles    Abstract available



  69. LIN KJ , Cheung WY, Lai JY, Giovannucci EL, et al
    The effect of estrogen versus combined estrogen-progestogen therapy on the risk of colorectal cancer.
    Int J Cancer. 2011 Mar 1. doi: 10.1002/ijc.26026.
    PubMed     Text format     Related articles   



    February 2011
  70. ZANUTTO S , Pizzamiglio S, Lampis A, Camerini T, et al
    Methylation status in early stage colon cancer patients: A new prognostic marker?
    Int J Cancer. 2011 Feb 23. doi: 10.1002/ijc.26011.
    PubMed     Text format     Related articles   



  71. ANDERSEN CL , Lamy P, Orntoft TF
    Are CIMP and chr16p13.2 copy number status independent prognostic markers in stage II and III colorectal cancer?
    Int J Cancer. 2011 Feb 23. doi: 10.1002/ijc.25998.
    PubMed     Text format     Related articles   



  72. NAYAK TK , Garmestani K, Baidoo KE, Milenic DE, et al
    PET imaging of tumor angiogenesis in mice with VEGF-A-targeted (86)Y-CHX-A''-DTPA-bevacizumab.
    Int J Cancer. 2011;128:920-6.
    PubMed     Text format     Related articles    Abstract available



  73. DIETRICH CG , Vehr AK, Martin IV, Gassler N, et al
    Downregulation of breast cancer resistance protein in colon adenomas reduces cellular xenobiotic resistance and leads to accumulation of a food-derived carcinogen.
    Int J Cancer. 2011 Feb 3. doi: 10.1002/ijc.25958.
    PubMed     Text format     Related articles   



  74. BIRAN A , Brownstein M, Haklai R, Kloog Y, et al
    Downregulation of survivin and aurora A by histone deacetylase and RAS inhibitors: a new drug combination for cancer therapy.
    Int J Cancer. 2011;128:691-701.
    PubMed     Text format     Related articles    Abstract available



  75. FRIEDMAN GD , Udaltsova N, Habel LA
    Norepinephrine antagonists and cancer risk.
    Int J Cancer. 2011;128:737-8.
    PubMed     Text format     Related articles   



    January 2011
  76. BARROW H , Rhodes JM, Yu LG
    The role of galectins in colorectal cancer progression.
    Int J Cancer. 2011 Jan 20. doi: 10.1002/ijc.25945.
    PubMed     Text format     Related articles   



  77. NAGAHARA M , Nishida N, Iwatsuki M, Ishimaru S, et al
    Kinesin 18A expression clinical relevance to colorectal cancer progression.
    Int J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



    December 2010
  78. GYLFE AE , Sirkia J, Ahlsten M, Jarvinen H, et al
    Somatic mutations and germline sequence variants in patients with familial colorectal cancer.
    Int J Cancer. 2010;127:2974-80.
    PubMed     Text format     Related articles    Abstract available



  79. FRANK B , Hoffmeister M, Klopp N, Illig T, et al
    Polymorphisms in inflammatory pathway genes and their association with colorectal cancer risk.
    Int J Cancer. 2010;127:2822-30.
    PubMed     Text format     Related articles    Abstract available



  80. BYEON JS , Jeong JY, Kim MJ, Lee SM, et al
    Adiponectin and adiponectin receptor in relation to colorectal cancer progression.
    Int J Cancer. 2010;127:2758-67.
    PubMed     Text format     Related articles    Abstract available



    September 2010
  81. ABRAMOWITZ L , Jacquard AC, Jaroud F, Haesebaert J, et al
    Human papillomavirus genotype distribution in anal cancer in France: The EDiTH V study.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



    May 2010
  82. GANDINI S , Boniol M, Haukka J, Byrnes G, et al
    Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



    April 2010
  83. KANG DW , Park MH, Lee YJ, Kim HS, et al
    Autoregulation of phospholipase d activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: